Inogen Inc (NASDAQ:INGN) Stock Is Shorted Less

Inogen, Inc. (NASDAQ:INGN) Logo

Investors sentiment decreased to 0.83 in Q2 2019. Its down 0.42, from 1.25 in 2019Q1. It worsened, as 47 investors sold Inogen, Inc. shares while 58 reduced holdings. 31 funds opened positions while 56 raised stakes. 22.43 million shares or 0.38% more from 22.35 million shares in 2019Q1 were reported.
Financial Bank Of New York Mellon stated it has 196,035 shares or 0% of all its holdings. Arizona State Retirement System owns 13,051 shares. Redmond Asset Ltd Liability Co reported 23,227 shares. Fred Alger Incorporated holds 889,637 shares or 0.23% of its portfolio. State Common Retirement Fund holds 0.04% or 492,081 shares. Legal General Pcl holds 22,026 shares or 0% of its portfolio. 6,646 were reported by Hsbc Plc. Blair William & Il stated it has 0.07% in Inogen, Inc. (NASDAQ:INGN). Ftb Advsrs holds 0% in Inogen, Inc. (NASDAQ:INGN) or 125 shares. Northern Tru holds 0.01% or 329,196 shares. Massmutual Co Fsb Adv stated it has 0% of its portfolio in Inogen, Inc. (NASDAQ:INGN). New York State Teachers Retirement Systems stated it has 0% of its portfolio in Inogen, Inc. (NASDAQ:INGN). Utd Automobile Association owns 41,375 shares. Alliancebernstein Limited Partnership reported 0% of its portfolio in Inogen, Inc. (NASDAQ:INGN). California Pub Employees Retirement System holds 22,722 shares or 0% of its portfolio.

The stock of Inogen Inc (NASDAQ:INGN) registered a decrease of 10.71% in short interest. INGN’s total short interest was 3.54 million shares in September as published by FINRA. Its down 10.71% from 3.96 million shares, reported previously. With 584,700 shares average volume, it will take short sellers 6 days to cover their INGN’s short positions. The short interest to Inogen Inc’s float is 19.63%.

The stock increased 2.79% or $1.31 during the last trading session, reaching $48.4. About 1.14M shares traded or 120.49% up from the average. Inogen, Inc. (NASDAQ:INGN) has declined 68.45% since September 13, 2018 and is downtrending. It has underperformed by 68.45% the S&P500.

Inogen, Inc., a medical technology company, primarily develops, makes, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. The company has market cap of $1.06 billion. The companyÂ’s oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It has a 25.99 P/E ratio. It offers Inogen One systems, which are portable devices that concentrate the air around the patients to provide a single source of supplemental oxygen; and Inogen At Home stationary oxygen concentrators, as well as related accessories.

Inogen, Inc. (NASDAQ:INGN) Ratings Coverage

Among 2 analysts covering Inogen (NASDAQ:INGN), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 0 are positive. Inogen has $17500 highest and $4700 lowest target. $90’s average target is 85.95% above currents $48.4 stock price. Inogen had 5 analyst reports since May 7, 2019 according to SRatingsIntel. The firm has “Market Perform” rating by Leerink Swann given on Thursday, August 8. The company was downgraded on Thursday, August 8 by Stifel Nicolaus.

More notable recent Inogen, Inc. (NASDAQ:INGN) news were published by: which released: “Park Hotels & Resorts (PK) Set to Join S&P MidCap 400; Inogen (INGN) to Join S&P SmallCap 600 –” on September 12, 2019, also with their article: “Inogen (INGN) Down 6.8% Since Last Earnings Report: Can It Rebound? – Nasdaq” published on June 06, 2019, published: “RSI Alert: Inogen (INGN) Now Oversold – Nasdaq” on July 23, 2019. More interesting news about Inogen, Inc. (NASDAQ:INGN) were released by: and their article: “Why the Earnings Surprise Streak Could Continue for Inogen (INGN) – Nasdaq” published on May 06, 2019 as well as‘s news article titled: “Earnings Preview: Inogen (INGN) Q2 Earnings Expected to Decline – Nasdaq” with publication date: July 31, 2019.

Inogen, Inc. (NASDAQ:INGN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.